249 related articles for article (PubMed ID: 19720090)
1. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
Zhang HS; Wu MR
Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
4. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
Zhang HS; Sang WW; Wang YO; Liu W
J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 regulates HIV transcription via Tat deacetylation.
Pagans S; Pedal A; North BJ; Kaehlcke K; Marshall BL; Dorr A; Hetzer-Egger C; Henklein P; Frye R; McBurney MW; Hruby H; Jung M; Verdin E; Ott M
PLoS Biol; 2005 Feb; 3(2):e41. PubMed ID: 15719057
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
8. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
Zhang HS; Wu TC; Sang WW; Ruan Z
Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
[TBL] [Abstract][Full Text] [Related]
9. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
[TBL] [Abstract][Full Text] [Related]
10. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.
Chen S; Xiao X; Feng X; Li W; Zhou N; Zheng L; Sun Y; Zhang Z; Zhu W
J Nutr Biochem; 2012 Sep; 23(9):1100-12. PubMed ID: 22137261
[TBL] [Abstract][Full Text] [Related]
13. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Zhang HS; Sang WW; Ruan Z; Wang YO
Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway.
Thakur BK; Chandra A; Dittrich T; Welte K; Chandra P
Biochem Biophys Res Commun; 2012 Jul; 424(2):245-50. PubMed ID: 22732402
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation.
Lin JN; Lin VC; Rau KM; Shieh PC; Kuo DH; Shieh JC; Chen WJ; Tsai SC; Way TD
J Agric Food Chem; 2010 Feb; 58(3):1584-92. PubMed ID: 19928762
[TBL] [Abstract][Full Text] [Related]
16. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.
Sun Y; Li J; Xiao N; Wang M; Kou J; Qi L; Huang F; Liu B; Liu K
Pharmacol Res; 2014 Nov; 89():19-28. PubMed ID: 25108154
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 replication is inhibited by a pseudo-substrate peptide that blocks Tat transactivation.
Okamoto H; Cujec TP; Peterlin BM; Okamoto T
Virology; 2000 May; 270(2):337-44. PubMed ID: 10792993
[TBL] [Abstract][Full Text] [Related]
19. A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia.
Wang LM; Wang YJ; Cui M; Luo WJ; Wang XJ; Barber PA; Chen ZY
Eur J Neurosci; 2013 May; 37(10):1669-81. PubMed ID: 23461657
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
Tang BL
Brain Res Bull; 2010 Mar; 81(4-5):359-61. PubMed ID: 20026255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
